{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:57:36Z","timestamp":1789790256472,"version":"4.0.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cyto.2023.156376","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:38:27Z","timestamp":1695465507000},"page":"156376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer"],"prefix":"10.1016","volume":"171","author":[{"given":"Asif Ahmad","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsas","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed Hassan","family":"almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami I.","family":"Alzarea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahaveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Rohilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun Kumar","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelima","family":"Kukreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanalekshmi Unnikrishnan","family":"Meenakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj Kumar","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendran","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41423-021-00735-3","article-title":"IFN\u03b3 signaling integrity in colorectal cancer immunity and immunotherapy","volume":"19","author":"Du","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156376_b0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: Teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2023.156376_b0015","doi-asserted-by":"crossref","first-page":"113683","DOI":"10.1016\/j.biopha.2022.113683","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cyto.2023.156376_b0020","doi-asserted-by":"crossref","first-page":"109568","DOI":"10.1016\/j.cbi.2021.109568","article-title":"Nuclear factor-kappa B and its role in inflammatory lung disease","volume":"345","author":"Alharbi","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11011-022-01095-1","article-title":"Targeting inflammation: a potential approach for the treatment of depression","volume":"38","author":"Bhatt","year":"2023","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0030","article-title":"Spatiotemporal control of engineered bacteria to express interferon-\u03b3 by focused ultrasound for tumor immunotherapy","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cyto.2023.156376_b0035","doi-asserted-by":"crossref","first-page":"a028480","DOI":"10.1101\/cshperspect.a028480","article-title":"Interferon \u03b3 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity","volume":"11","author":"Alspach","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156376_b0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0045","doi-asserted-by":"crossref","first-page":"e000599","DOI":"10.1136\/jitc-2020-000599","article-title":"Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-\u03b3, CXCL9 and CXCL10","volume":"8","author":"Bergamaschi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cyto.2023.156376_b0050","doi-asserted-by":"crossref","first-page":"101280","DOI":"10.1016\/j.smim.2019.05.002","article-title":"IFN-\u03b3: A cytokine at the right time, is in the right place","volume":"43","author":"Burke","year":"2019","journal-title":"Semin. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2023.156376_b0055","doi-asserted-by":"crossref","first-page":"e23174","DOI":"10.1002\/jbt.23174","article-title":"Exploring the role of antibiotics and steroids in managing respiratory diseases","volume":"36","author":"Chellappan","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156376_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/nu15041019","article-title":"Agarwood oil nanoemulsion attenuates cigarette smoke-induced inflammation and oxidative stress markers in BCi-NS1.1 airway epithelial cells","volume":"15","author":"De Rubis","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.cyto.2023.156376_b0065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2023.156376_b0070","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/1756-185X.13602","article-title":"Rosmarinic acid attenuates inflammation in experimentally induced arthritis in wistar rats, using freund's complete adjuvant","volume":"22","author":"Gautam","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0075","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cyto.2023.156376_b0080","doi-asserted-by":"crossref","first-page":"118973","DOI":"10.1016\/j.lfs.2020.118973","article-title":"Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities","volume":"267","author":"Lee","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cyto.2023.156376_b0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cbpa.2021.01.007","article-title":"Cytokine engineering for targeted cancer immunotherapy","volume":"62","author":"Bonati","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.cyto.2023.156376_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2019.02.021","article-title":"Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases","volume":"304","author":"Mehta","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.cyto.2023.156376_b0100","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0022034513500306","article-title":"Advances in the regulation of osteoclasts and osteoclast functions","volume":"92","author":"Boyce","year":"2013","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jir.2018.0019","article-title":"Cytokines in the treatment of cancer","volume":"39","author":"Conlon","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2023.156376_b0110","doi-asserted-by":"crossref","first-page":"110334","DOI":"10.1016\/j.cbi.2023.110334","article-title":"Janus kinase\/signal transducers and activator of transcription (JAK\/STAT) and its role in lung inflammatory disease","volume":"371","author":"Purohit","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"19","key":"10.1016\/j.cyto.2023.156376_b0115","doi-asserted-by":"crossref","first-page":"11740","DOI":"10.3390\/ijms231911740","article-title":"Cytokine storm-definition, causes, and implications","volume":"23","author":"Jarczak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.cyto.2023.156376_b0120","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4155\/fmc-2020-0190","article-title":"Targeting interleukins in chronic airway diseases using advanced drug delivery","volume":"12","author":"Satija","year":"2020","journal-title":"Future Med. Chem."},{"issue":"15","key":"10.1016\/j.cyto.2023.156376_b0125","doi-asserted-by":"crossref","first-page":"e2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From clinical significance to quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci (weinh)"},{"issue":"3","key":"10.1016\/j.cyto.2023.156376_b0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41368-019-0064-z","article-title":"The cytokine network involved in the host immune response to periodontitis","volume":"11","author":"Pan","year":"2019","journal-title":"Int. J. Oral Sci."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jir.2018.0087","article-title":"The interferon-gamma paradox in cancer","volume":"39","author":"Zaidi","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"issue":"34","key":"10.1016\/j.cyto.2023.156376_b0140","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9506","article-title":"Interferon-\u03b3 signaling in human iPSC-derived neurons recapitulates neurodevelopmental disorder phenotypes","volume":"6","author":"Warre-Cornish","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cyto.2023.156376_b0145","doi-asserted-by":"crossref","first-page":"108947","DOI":"10.1016\/j.cbi.2020.108947","article-title":"Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases","volume":"317","author":"Tew","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22183","article-title":"More significance of TB-IGRA except for the diagnose of tuberculosis","volume":"32","author":"Xu","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"12","key":"10.1016\/j.cyto.2023.156376_b0155","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2023.156376_b0160","doi-asserted-by":"crossref","first-page":"e2705","DOI":"10.1093\/cid\/ciaa1274","article-title":"Primary and acquired immunodeficiencies associated with severe varicella-zoster virus infections","volume":"73","author":"Ansari","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cyto.2023.156376_b0165","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5604\/17322693.1101229","article-title":"Interferons: Between structure and function","volume":"68","author":"Bandurska","year":"2014","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.cyto.2023.156376_b0170","doi-asserted-by":"crossref","first-page":"110482","DOI":"10.1016\/j.cbi.2023.110482","article-title":"Galangin as an inflammatory response modulator: An updated overview and therapeutic potential","volume":"378","author":"Thapa","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","article-title":"How cancer cells make and respond to interferon-I","volume":"9","author":"Cheon","year":"2023","journal-title":"Trends Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2023.156376_b0180","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1002\/cam4.1700","article-title":"Interferon gamma in cancer immunotherapy","volume":"7","author":"Ni","year":"2018","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.cyto.2023.156376_b0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41423-019-0237-x","article-title":"ZBP1 mediates interferon-induced necroptosis","volume":"17","author":"Yang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156376_b0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CM9.0000000000001558","article-title":"Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer","volume":"135","author":"Zhuang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.cyto.2023.156376_b0195","doi-asserted-by":"crossref","first-page":"8011988","DOI":"10.1155\/2022\/8011988","article-title":"Quercetin alleviates the progression of breast cancer-related depression via inhibiting the pyroptosis and promoting the immune response","volume":"2022","author":"Zhu","year":"2022","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0200","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","article-title":"MUC1: A multifaceted oncoprotein with a key role in cancer progression","volume":"20","author":"Nath","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.cyto.2023.156376_b0205","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.3390\/ijms22126567","article-title":"MUC1: Structure, function, and clinic application in epithelial cancers","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0210","doi-asserted-by":"crossref","first-page":"e002115","DOI":"10.1136\/jitc-2020-002115","article-title":"MUC1-C integrates activation of the IFN-\u03b3 pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer","volume":"9","author":"Yamashita","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.cyto.2023.156376_b0215","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1158\/0008-5472.CAN-15-1538","article-title":"Immunoregulatory protein B7-H3 reprograms glucose metabolism in cancer cells by ROS-mediated stabilization of HIF1\u03b1","volume":"76","author":"Lim","year":"2016","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0220","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01364-7","article-title":"Immune checkpoint of B7\u2013H3 in cancer: From immunology to clinical immunotherapy","volume":"15","author":"Zhao","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cyto.2023.156376_b0225","doi-asserted-by":"crossref","first-page":"153461","DOI":"10.1016\/j.prp.2021.153461","article-title":"B7\u2013H3 on breast cancer cell MCF7 inhibits IFN-\u03b3 release from tumour-infiltrating T cells","volume":"224","author":"Shao","year":"2021","journal-title":"Pathology - Research and Practice"},{"key":"10.1016\/j.cyto.2023.156376_b0230","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fonc.2020.00899","article-title":"The role of tumor-associated myeloid cells in modulating cancer therapy","volume":"10","author":"Neophytou","year":"2020","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2023.156376_b0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.cyto.2023.156376_b0240","doi-asserted-by":"crossref","first-page":"108482","DOI":"10.1016\/j.celrep.2020.108482","article-title":"Regulatory T cells support breast cancer progression by opposing IFN-\u03b3-dependent functional reprogramming of myeloid cells","volume":"33","author":"Clark","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.cyto.2023.156376_b0245","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.cyto.2023.156376_b0250","doi-asserted-by":"crossref","first-page":"e10608","DOI":"10.1016\/j.heliyon.2022.e10608","article-title":"Cisplatin for cancer therapy and overcoming chemoresistance","volume":"8","author":"Ranasinghe","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0255","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ijms21010170","article-title":"Single cell mass cytometry revealed the immunomodulatory effect of cisplatin via downregulation of splenic CD44+, IL-17A+ MDSCs and promotion of circulating IFN-\u03b3+ myeloid cells in the 4T1 metastatic breast cancer model","volume":"21","author":"Balog","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0260","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01788-4","article-title":"The immunomodulatory effects of endocrine therapy in breast cancer","volume":"40","author":"Huang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0265","doi-asserted-by":"crossref","first-page":"e87377","DOI":"10.1371\/journal.pone.0087377","article-title":"Activation of ER\u03b1 signaling differentially modulates IFN-\u03b3 induced HLA-class II expression in breast cancer cells","volume":"9","author":"Mostafa","year":"2014","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.cyto.2023.156376_b0270","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.7150\/thno.41648","article-title":"Stem cell programs in cancer initiation, progression, and therapy resistance","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cyto.2023.156376_b0275","doi-asserted-by":"crossref","first-page":"621294","DOI":"10.3389\/fonc.2020.621294","article-title":"Ubiquitination of nonhistone proteins in cancer development and treatment","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cyto.2023.156376_b0280","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","volume":"35","author":"Mohammad","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156376_b0285","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ymthe.2020.12.037","article-title":"Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway","volume":"29","author":"Jia","year":"2021","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0290","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7314\/APJCP.2014.15.1.265","article-title":"Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model","volume":"15","author":"Yuan","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.cyto.2023.156376_b0295","unstructured":"L.F. Vinicius et al. Cytokines and Interferons: Types and Functions, in Autoantibodies and Cytokines K. Wahid Ali, Editor. 2018, IntechOpen: Rijeka. p. Ch. 4."},{"key":"10.1016\/j.cyto.2023.156376_b0300","doi-asserted-by":"crossref","first-page":"154105","DOI":"10.1016\/j.phymed.2022.154105","article-title":"Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways","volume":"101","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.cyto.2023.156376_b0305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.bmt.1705692","article-title":"Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-\u03b3 after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer","volume":"40","author":"Vahdat","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"16","key":"10.1016\/j.cyto.2023.156376_b0310","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1002\/cam4.2560","article-title":"Ovarian cancer: Current status and strategies for improving therapeutic outcomes","volume":"8","author":"Chandra","year":"2019","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.cyto.2023.156376_b0315","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0019-509X.154049","article-title":"Advances in tumor markers of ovarian cancer for early diagnosis","volume":"51","author":"Dong","year":"2014","journal-title":"Indian J. Cancer"},{"issue":"suppl_8","key":"10.1016\/j.cyto.2023.156376_b0320","doi-asserted-by":"crossref","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","article-title":"Real-world evidence in the treatment of ovarian cancer","volume":"28","author":"Eisenhauer","year":"2017","journal-title":"Ann Oncol"},{"issue":"1-2","key":"10.1016\/j.cyto.2023.156376_b0325","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000479006","article-title":"Ovarian cancer: A heterogeneous disease","volume":"85","author":"Kossa\u00ef","year":"2018","journal-title":"Pathobiology"},{"issue":"24","key":"10.1016\/j.cyto.2023.156376_b0330","first-page":"6643","article-title":"Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer","volume":"51","author":"Malik","year":"1991","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cyto.2023.156376_b0335","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/cancers12092402","article-title":"Midkine is a potential therapeutic target of tumorigenesis, angiogenesis, and metastasis in non-small cell lung cancer","volume":"12","author":"Shin","year":"2020","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.cyto.2023.156376_b0340","article-title":"Combined usage of MDK inhibitor augments interferon-\u03b3 Anti-tumor activity in the SKOV3 human ovarian cancer cell line","volume":"11","author":"Liu","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.cyto.2023.156376_b0345","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.4049\/jimmunol.152.7.3693","article-title":"A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes","volume":"152","author":"Puri","year":"1994","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0350","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1026294416718","article-title":"Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy","volume":"65","author":"Kawakami","year":"2003","journal-title":"J. Neurooncol"},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0355","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/imt-2018-0158","article-title":"Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-\u03b1 and IFN-\u03b3 mediate antitumor effects in vitro and in a mouse model of human ovarian cancer","volume":"11","author":"Green","year":"2019","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.cyto.2023.156376_b0360","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/vaccines10050816","article-title":"Harnessing the immune system with cancer vaccines: From prevention to therapeutics","volume":"10","author":"Le","year":"2022","journal-title":"Vaccines (basel)"},{"issue":"5","key":"10.1016\/j.cyto.2023.156376_b0365","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1758834014544121","article-title":"Treatment options in recurrent ovarian cancer: Latest evidence and clinical potential","volume":"6","author":"Luvero","year":"2014","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0370","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1080\/21691401.2019.1646749","article-title":"Luteolin exhibits anti-breast cancer property through up-regulating miR-203","volume":"47","author":"Gao","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.cyto.2023.156376_b0375","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.2147\/OTT.S205950","article-title":"Immunotherapy for ovarian cancer: Recent advances and combination therapeutic approaches","volume":"13","author":"Palaia","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0380","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: A review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.cyto.2023.156376_b0385","doi-asserted-by":"crossref","first-page":"154865","DOI":"10.1016\/j.phymed.2023.154865","article-title":"Luteolin inhibits subretinal fibrosis and epithelial-mesenchymal transition in laser-induced mouse model via suppression of Smad2\/3 and YAP signaling","volume":"116","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.cyto.2023.156376_b0390","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: Where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"issue":"10066","key":"10.1016\/j.cyto.2023.156376_b0395","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: Current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.cyto.2023.156376_b0400","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.3390\/ijms22168661","article-title":"Current and future development in lung cancer diagnosis","volume":"22","author":"Nooreldeen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0405","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.7861\/clinmed.2021-0657","article-title":"Lung cancer for the non-respiratory physician","volume":"21","author":"O'Dowd","year":"2021","journal-title":"Clin. Med. (Lond.)"},{"issue":"3","key":"10.1016\/j.cyto.2023.156376_b0410","first-page":"727","article-title":"PD-1\/PD-L1 pathway: Current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.cyto.2023.156376_b0415","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.18632\/oncotarget.13895","article-title":"PD-1 and its ligands are important immune checkpoints in cancer","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cyto.2023.156376_b0420","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ijc.31357","article-title":"IFN-\u03b3-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling","volume":"143","author":"Gao","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2023.156376_b0425","first-page":"1","article-title":"An overview of the molecular mechanism of autophagy","volume":"335","author":"Yang","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0430","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: Cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0435","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1962591","article-title":"IFN-\u03b3-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells","volume":"10","author":"Fang","year":"2021","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0440","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/pharmaceutics14010073","article-title":"CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials","volume":"14","author":"Zhang","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cyto.2023.156376_b0445","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fnut.2019.00140","article-title":"Cooperation of oligodeoxynucleotides and synthetic molecules as enhanced immune modulators","volume":"6","author":"Nigar","year":"2019","journal-title":"Front. Nutr."},{"issue":"4","key":"10.1016\/j.cyto.2023.156376_b0450","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1759-7714.13351","article-title":"Class A CpG oligodeoxynucleotide inhibits IFN-\u03b3-induced signaling and apoptosis in lung cancer","volume":"11","author":"Teranishi","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.cyto.2023.156376_b0455","doi-asserted-by":"crossref","first-page":"117990","DOI":"10.1016\/j.lfs.2020.117990","article-title":"Combination of luteolin and lycopene effectively protect against the \u201ctwo-hit\u201d in NAFLD through Sirt1\/AMPK signal pathway","volume":"256","author":"Zhu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0460","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: Global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"2","key":"10.1016\/j.cyto.2023.156376_b0465","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1208\/s12248-010-9181-5","article-title":"Pancreatic cancer: Pathobiology, treatment options, and drug delivery","volume":"12","author":"Li","year":"2010","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0470","doi-asserted-by":"crossref","first-page":"e000308","DOI":"10.1136\/jitc-2019-000308","article-title":"Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2023.156376_b0475","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.7150\/jca.57334","article-title":"A snapshot of the PD-1\/PD-L1 pathway","volume":"12","author":"Ghosh","year":"2021","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.cyto.2023.156376_b0480","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156376_b0485","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026716","article-title":"Caspase functions in cell death and disease","volume":"7","author":"McIlwain","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.cyto.2023.156376_b0490","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.49.2.251","article-title":"Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis","volume":"49","author":"Detjen","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0495","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6145-8","article-title":"IFN-\u03b3 down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer","volume":"19","author":"Ding","year":"2019","journal-title":"BMC Cancer"},{"issue":"23","key":"10.1016\/j.cyto.2023.156376_b0500","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/cells11233744","article-title":"Comprehensive review of biomarkers for the treatment of locally advanced colon cancer","volume":"11","author":"Chuang","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0505","doi-asserted-by":"crossref","first-page":"37","DOI":"10.31557\/APJCP.2021.22.1.37","article-title":"Modifiable factors and colon cancer risk in thai population","volume":"22","author":"Chottanapund","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"8","key":"10.1016\/j.cyto.2023.156376_b0510","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1080\/15384047.2019.1599660","article-title":"Colon cancer stem cells: Potential target for the treatment of colorectal cancer","volume":"20","author":"Gupta","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0515","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1748991","article-title":"B7\u2013H3 inhibits the IFN-\u03b3-dependent cytotoxicity of V\u03b39V\u03b42 T cells against colon cancer cells","volume":"9","author":"Lu","year":"2020","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.cyto.2023.156376_b0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: Current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0525","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.ajpath.2013.02.041","article-title":"IFN-\u03b3 mediates the antitumor effects of radiation therapy in a murine colon tumor","volume":"182","author":"Gerber","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2023.156376_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2016.11.007","article-title":"Plant flavonoids in cancer chemoprevention: Role in genome stability","volume":"45","author":"George","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0535","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.mcna.2020.08.007","article-title":"Screening for Prostate Cancer","volume":"104","author":"Carlsson","year":"2020","journal-title":"The Medical Clinics of North America"},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0540","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","article-title":"High-risk prostate cancer-classification and therapy","volume":"11","author":"Chang","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156376_b0545","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"17","key":"10.1016\/j.cyto.2023.156376_b0550","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"43","key":"10.1016\/j.cyto.2023.156376_b0555","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.1705536114","article-title":"Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-\u03b3","volume":"114","author":"Kundu","year":"2017","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0560","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1038\/s41598-022-10724-9","article-title":"Interferon-\u03b3 increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer","volume":"12","author":"Korentzelos","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.cyto.2023.156376_b0565","doi-asserted-by":"crossref","first-page":"e0162956","DOI":"10.1371\/journal.pone.0162956","article-title":"Dietary Flavones as dual inhibitors of DNA methyltransferases and histone methyltransferases","volume":"11","author":"Kanwal","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cyto.2023.156376_b0570","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.3390\/ijms23105384","article-title":"Molecular pathology of skin melanoma: Epidemiology, differential diagnostics, prognosis and therapy prediction","volume":"23","author":"T\u00edm\u00e1r","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cyto.2023.156376_b0575","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.3390\/cells10092320","article-title":"Molecular markers and targets in melanoma","volume":"10","author":"Teixido","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0580","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11864-019-0607-8","article-title":"Targeted therapy and immunotherapy for melanoma in japan","volume":"20","author":"Namikawa","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0585","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-35348-5","article-title":"Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis","volume":"14","author":"Arimoto","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0590","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-13-132","article-title":"USP18 is crucial for IFN-\u03b3-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity","volume":"13","author":"Hong","year":"2014","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2023.156376_b0595","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/eji.202048992","article-title":"Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy","volume":"51","author":"Dees","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0600","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: New mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.cyto.2023.156376_b0605","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-\u03b3 drives T(reg) fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2023.156376_b0610","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1080\/13880209.2021.1999275","article-title":"Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis","volume":"59","author":"Zhou","year":"2021","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156376_b0615","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ijc.2910550224","article-title":"Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene","volume":"55","author":"Lollini","year":"1993","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cyto.2023.156376_b0620","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41556-020-0495-y","article-title":"Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-\u03b3 signalling","volume":"22","author":"Singh","year":"2020","journal-title":"Nat. Cell Biol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:08:10Z","timestamp":1736417290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623002545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":124,"alternative-id":["S1043466623002545"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156376","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156376"}}